As one of the major risks for urolithiasis, hyperoxaluria can be caused by genetic defect or dietary intake. And high oxalate induced renal epithelial cells injury is related to oxidative stress and mitochondrial dysfunction. Here, we investigated whether MitoTEMPO, a mitochondria‐targeted antioxidant, could protect against oxalate mediated injury in NRK‐52E cells via inhibiting mitochondrial dysfunction and modulating oxidative stress. MitoSOX Red was used to determine mitochondrial ROS (mtROS) production. Mitochondrial membrane potential (Δψm) and quantification of ATP synthesis were measured to evaluate mitochondrial function. The protein expression of Nox4, Nox2, and p22 was also detected to explore the effect of oxalate and MitoTEMPO on NADPH oxidase. Our results revealed that pretreatment with MitoTEMPO significantly inhibited oxalate induced lactate dehydrogenase (LDH) and malondialdehyde (MDA) release and decreased oxalate induced mtROS generation. Further, MitoTEMPO pretreatment restored disruption of Δψm and decreased ATP synthesis mediated by oxalate. In addition, MitoTEMPO altered the protein expression of Nox4 and p22 and decreased the protein expression of IL‐6 and osteopontin (OPN) induced by oxalate. We concluded that MitoTEMPO may be a new candidate to protect against oxalate induced kidney injury as well as urolithiasis.
1 January 2018 in Oxidative Medicine and Cellular Longevity
Calcium oxalate (CaOx) is the most common type of urinary stone. Increase of ROS and NADPH oxidase gives rise to inflammation and injury of renal tubular cells, which promotes CaOx stone formation. Recent studies have revealed that the renin‐angiotensin system might play a role in kidney crystallization and ROS production. Here, we investigated the involvement of Ang II/AT1R and losartan in CaOx stone formation. NRK‐52E cells were incubated with CaOx crystals, and glyoxylic acid‐induced hyperoxaluric rats were treated with losartan. Oxidative stress statuses were evaluated by detection of ROS, oxidative products (8‐OHdG and MDA), and antioxidant enzymes (SOD and CAT). Expression of NADPH oxidase subunits (Nox2 and Nox4), NF‐κB pathway subunits (p50 and p65), and stone‐related proteins such as OPN, CD44, and MCP‐1 was determined by Western blotting. The results revealed upregulation of Ang II/AT1R by CaOx treatment. CaOx‐induced ROS and stone‐related protein upregulation were mediated by the Ang II/AT1R signaling pathway. Losartan ameliorated renal tubular cell expression of stone‐related proteins and renal crystallization by inhibiting NADPH oxidase and oxidative stress. We conclude that losartan might be a promising preventive and therapeutic candidate for hyperoxaluria nephrolithiasis.
Muriod is the most successful one among rodents struggling for existence, and biologists have been paying much attention to it, especially Mus musculus. Because of the thorough study on Mus musculus, it has been widely applied in lab, and becomes a good material for studying other animals. Phylogenetic relationship between different species and populations of Mus and Microtus are more clearly revealed with some genetic markers of modern genetics, such as protein, mtDNA, and rDNA. Taxonomy and evolution of species of both genus have also been revealed. Whereas the taxonomy and genetic relationships of some species and populations between both genus need to be further studied.